Interestingly, different rodent models of TLR4 ablation, either genetically modified by knock-out approaches (Poggi et al., 2007; Jia et al., 2014; Li et al., 2014) or by pharmacological inhibition (Zhang et al., 2015), have shown to prevent HFD-induced insulin resistance. This evidence concerns the gene TLR4 and Insulin resistance.